Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Calcineurin and beyond: cardiac hypertrophic signaling.

Molkentin JD.

Circ Res. 2000 Oct 27;87(9):731-8. Review.

2.
3.

Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.

Wilkins BJ, Molkentin JD.

Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91. Review.

PMID:
15336966
5.

Cardiac hypertrophy: sorting out the circuitry.

McKinsey TA, Olson EN.

Curr Opin Genet Dev. 1999 Jun;9(3):267-74. Review.

PMID:
10377279
6.
7.

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD.

J Mol Cell Cardiol. 2000 Apr;32(4):697-709.

PMID:
10756124
8.

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN.

J Clin Invest. 2000 May;105(10):1395-406.

9.

Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation.

Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S.

EMBO Rep. 2000 Nov;1(5):428-34.

10.

Signaling path may lead to better heart-failure therapies.

Barinaga M.

Science. 1998 Apr 17;280(5362):383. No abstract available.

PMID:
9575084
11.

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD.

Circ Res. 2004 Jan 9;94(1):110-8.

12.

Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.

Kato T, Sano M, Miyoshi S, Sato T, Hakuno D, Ishida H, Kinoshita-Nakazawa H, Fukuda K, Ogawa S.

Circ Res. 2000 Nov 10;87(10):937-45.

14.

The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells.

Hirotani H, Tuohy NA, Woo JT, Stern PH, Clipstone NA.

J Biol Chem. 2004 Apr 2;279(14):13984-92.

15.

Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.

Zhang W.

Cardiovasc Res. 2002 Feb 1;53(2):294-303. Review.

PMID:
11827679
16.

Calcineurin mutants render T lymphocytes resistant to cyclosporin A.

Zhu D, Cardenas ME, Heitman J.

Mol Pharmacol. 1996 Sep;50(3):506-11.

PMID:
8794888
17.

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.

Crabtree GR.

Cell. 1999 Mar 5;96(5):611-4. Review. No abstract available.

18.

Regulation of MAPK signaling pathways through immunophilin-ligand complex.

Matsuda S, Koyasu S.

Curr Top Med Chem. 2003;3(12):1358-67. Review.

PMID:
12871167
19.

Calcineurin in human heart hypertrophy.

Ritter O, Hack S, Schuh K, Röthlein N, Perrot A, Osterziel KJ, Schulte HD, Neyses L.

Circulation. 2002 May 14;105(19):2265-9.

Supplemental Content

Support Center